Johnson & Johnson (JNJ) Poaches Merck & Co. (MRK) Exec to Run Pharma R&D
Johnson & Johnson (JNJ) | June 08, 2017
Johnson & Johnson (JNJ) appears to be planning some big moves with its pharma pipeline. The company reportedly hired Merck (MRK)’s Mathai Mammen to helm J&J’s research and development unit. Mammen will replace Bill Hait who is taking over the reins of external innovation at J&J, Endpoints first reported this morning. According to the Endpoints report, Mammen will join Johnson & Johnson later this month, then assume the reins of the R&D unit in 2018.